Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Cellgram-LC for efficacy and safety in patients with alcoholic cirrhosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Cirrhosis

Drugs mentioned

• Cellgram-LC

Snippet

Sponsor: Pharmicell Co., Ltd. | Conditions: Alcoholic Cirrhosis | Phase 3 | Status: RECRUITING